This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignee: The General Hospital Corporation. Active years: 2016-2019.
Location History:
- Somerville, MA (US) (2016)
- Berkeley, CA (US) (2019)
Company Filing History:
Years Active: 2016-2019
Title: David Kokel: Innovator in Neuroactive Compounds
Introduction
David Kokel is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of neuroactive compounds, focusing on treatments for psychotic disorders. With a total of 2 patents, Kokel's work is at the forefront of neuropharmacology.
Latest Patents
Kokel's latest patents include innovative methods and compounds aimed at addressing psychotic disorders. One of his notable inventions is titled "Neuroactive compounds and methods of using the same." This invention relates to neuroactive compounds and compositions designed for the treatment of psychotic disorders. It also includes methods for treating psychosis using these compounds and screening for novel neuroactive compounds. A key aspect of this patent involves a family of compounds known as 'finazines' and in vivo screening methods utilizing high-throughput behavioral assays in zebrafish.
Another significant patent is "Compositions and methods for controlling neuronal excitation." This technology focuses on methods to modulate neuron activity by using photo-sensitive TrpA1 agonists, which are illuminated with electromagnetic radiation. This innovative approach opens new avenues for controlling neuronal excitation and understanding neuronal behavior.
Career Highlights
David Kokel is associated with The General Hospital Corporation, where he continues to advance his research and development in neuroactive compounds. His work is characterized by a commitment to improving mental health treatments through innovative scientific approaches.
Collaborations
Kokel collaborates with esteemed colleagues, including Randall T Peterson and Chung Yan J Cheung. Their combined expertise enhances the research and development of neuroactive compounds, contributing to the advancement of the field.
Conclusion
David Kokel's contributions to neuroactive compounds and methods for treating psychotic disorders highlight his role as an influential inventor in the field. His innovative patents and collaborations reflect a dedication to improving mental health treatments through scientific innovation.